Search Results

Your search matched 5 results

#1

AVOID THE PRICE CRISIS | In The Media

Meg Alexander, Managing Director of our Reputation & Risk Management Practice, writes about how to avoid the price crisis in this article for PM360.

#2

PATIENT ASSISTANCE PROGRAMS: NEXT ISSUE TO PUT PHARMA IN THE PENALTY BOX? | In The Media

The time was 10 AM on the morning of April 18, 2016, when Michael Pearson, beleaguered CEO of Valeant Pharmaceuticals, sat down before the U.S.

#3

NAVIGATING IN A NEW AGE OF POPULISM | In The Media

On first reflection, the word populist may conjure vague recollections from sophomore year American history class and images of Huey Long from cobweb-covered corners of the memory.

#4

PUSHBACK ON RARE DRUG PRICES: NOT SO RARE AFTER ALL | In The Media

There’s no doubt the “pricing crisis,” has taken a heavy toll on the reputation of the biopharmaceutical industry.

#5

TRUMP OR CLINTON? | In The Media

The Mental Health Parity and Addiction Equity Act of 2008 forged a legal framework to guarantee people with mental health conditions the same access to care and coverage as those with physical conditions or injuries.